From Promise to Practice: Recent Growth in 30 Years of Tissue Engineering Commercialization.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 38818800.
- Also identified by DOI 10.1089/ten.TEA.2024.0112.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This perspective, marking the 30th anniversary of the Tissue Engineering journal, discusses the exciting trends in the global commercialization of tissue engineering technology. Within a historical context, we present an evolution of challenges and a discussion of the last 5 years of global commercial successes and emerging market trends, highlighting the continued expansion of the field in the northeastern United States. This leads to an overview of the last 5 years' progress in clinical trials for tissue-engineered therapeutics, including an analysis of trends in success and failure. Finally, we provide a broad overview of preclinical research and a perspective on where the state-of-the-art lies on the horizon.
Medical subject headings
- Tissue Engineering